Iga nephropathy with macroproteinuria and a gfr of 20-30ml/min/1.73m may still benefit from ras inhibition

HIGHLIGHTS

• who: Ying Wang and collaborators from the Department of Nephrology, China-Japan Friendship Hospital, Beijing, China have published the article: IgA Nephropathy with Macroproteinuria and a GFR of 20-30ml/min/1.73m May Still Benefit from RAS Inhibition, in the Journal: Journal of the Renin-Angiotensin-Aldosterone System of 30/Dec/2022
• what: The antibody used in this study was the antiangiotensin II type 1 receptor (AT1R) antibody (Abcam, ab124505, 1: 500), anti-angiotensin II type 2 receptor (AT2R) antibody (Abcam, ab254561, 1: 400), anti-Mas receptor (MasR) antibody (Abcam, ab66030, 1: 100), and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.